---
title: "Sunho Biologics CEO and Chief Scientific Officer Dr. Yin Liusong to Step Down"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/272979259.md"
description: "Sunho Biologics, Inc. announced that Dr. Yin Liusong will resign as CEO and Chief Scientific Officer effective February 28, 2026, to pursue other opportunities. He stated there is no disagreement with the board, and he will ensure a smooth transition while the company searches for replacements. This leadership change may impact the company's strategic direction. The current analyst rating for Sunho Biologics (HK:2898) is a Hold with a price target of HK$7.00."
datetime: "2026-01-19T13:37:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272979259.md)
  - [en](https://longbridge.com/en/news/272979259.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272979259.md)
---

# Sunho Biologics CEO and Chief Scientific Officer Dr. Yin Liusong to Step Down

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

An announcement from Sunho Biologics,Inc. ( (HK:2898) ) is now available.

Sunho Biologics, Inc. announced that Dr. Yin Liusong has tendered his resignation as executive director, chief executive officer and chief scientific officer, effective 28 February 2026, to pursue other personal and career opportunities. Dr. Yin has indicated there is no disagreement with the board or any matter requiring shareholder attention, and he will continue to perform his duties diligently until his departure to ensure a smooth transition, while the company seeks suitable candidates to fill the CEO and chief scientific officer roles, signaling a significant leadership change that may influence its strategic and scientific direction.

The most recent analyst rating on (HK:2898) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on Sunho Biologics,Inc. stock, see the HK:2898 Stock Forecast page.

**More about Sunho Biologics,Inc.**

Sunho Biologics, Inc. is a biotechnology company listed on the Hong Kong Stock Exchange and incorporated in the Cayman Islands, focused on developing biologic therapies, with its governance led by a board comprising executive, non-executive and independent non-executive directors.

**Average Trading Volume:** 10,551

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** HK$1.13B

Find detailed analytics on 2898 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [159987.CN](https://longbridge.com/en/quote/159987.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [02898.HK](https://longbridge.com/en/quote/02898.HK.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)

## Related News & Research

- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [HBM Holdings Says Director Probed by CSRC, Sees No Impact on Operations](https://longbridge.com/en/news/286197909.md)
- [Ab&B Bio-Tech Starts Early-Stage Trials for High-Yield RSV Vaccine as Trading Remains Suspended](https://longbridge.com/en/news/286268861.md)
- [01:00 ETNational Kidney Foundation Innovation Fund Invests in Biohope to Advance Personalized Medicine in Kidney Transplantation](https://longbridge.com/en/news/286359416.md)
- [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)